CRYSTAL SCHMIDT: Open Payments
NPI 1104540517 · ELIZABETHTON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$904 in 10 payments from 8 companies in 2025. Trend: 2023 $1,000 · 2024 $834 · 2025 $904
Food & beverage: $904
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 3 | $307 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| ABBVIE INC. | 1 | $123 |
| Neurocrine BioSciences, Inc. | 1 | $119 |
| Janssen Biotech, Inc. | 1 | $97 |
| AstraZeneca Pharmaceuticals LP | 1 | $61 |
| Gilead Sciences, Inc. | 1 | $54 |
| ACADIA Pharmaceuticals Inc | 1 | $17 |
Products named: Briviact, Nayzilam, Auvelity, UBRELVY, INGREZZA, TREMFYA, WAINUA, Livdelzi.
Industry payments across TN — which companies pay providers there.
